<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8"/>
    <meta property="og:url" content="https://www.washingtontimes.com/news/2019/nov/5/blueprint-medicines-3q-earnings-snapshot/"/>
    <meta property="og:site_name" content="The Washington Times"/>
    <meta property="article:published_time" content="2019-11-05T00:00:00+00:00"/>
    <meta property="og:title" content="Blueprint Medicines: 3Q Earnings Snapshot"/>
    <meta property="og:description" content="CAMBRIDGE, Mass. (AP) _ Blueprint Medicines Corp. (BPMC) on Tuesday reported a loss of $94.3 million in its third quarter."/>
  </head>
  <body>
    <article>
      <h1>Blueprint Medicines: 3Q Earnings Snapshot</h1>
      <address>
        <time datetime="2019-11-05T00:00:00+00:00">05 Nov 2019</time>
      </address>
      <p>CAMBRIDGE, Mass. (AP) _ Blueprint Medicines Corp. (BPMC) on Tuesday reported a loss of $94.3 million in its third quarter.</p>
      <p>On a per-share basis, the Cambridge, Massachusetts-based company said it had a loss of $1.93.</p>
      <p>The results exceeded Wall Street expectations. The average estimate of nine analysts surveyed by Zacks Investment Research was for a loss of $2.19 per share.</p>
      <p>The cancer drug developer posted revenue of $9.1 million in the period, also exceeding Street forecasts. Six analysts surveyed by Zacks expected $3.7 million.</p>
      <p>Blueprint Medicines shares have risen 25% since the beginning of the year. The stock has risen 2% in the last 12 months.</p>
      <hr/>
      <hr/>
      <anchor name="pagebreak">
        <p>This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on BPMC at https://www.zacks.com/ap/BPMC</p>
        <h3>Sign up for Daily Newsletters</h3>
        <p>
          <a href="https://www.washingtontimes.com/newsletters/manage/">Manage Newsletters</a>
        </p>
        <p>Copyright © 2019 The Washington Times, LLC.</p>
        <h4>Please read our <a href="https://www.washingtontimes.com/comment-policy/">comment policy</a> before commenting.</h4>
        <p> </p>
      </anchor>
    </article>
  </body>
</html>